Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-310
Royal Jelly Acid
Cat. No.
AKA-310
CAS No.
14113-05-4
MF
C10H18O3
MW
186.24812
Royal Jelly Acid ((E)-Queen Bee Acid) is a major fatty acid with oral bioavailability, exhibiting neuroregulatory activity.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Royal Jelly Acid
CAS No.
14113-05-4
MF
C10H18O3
MW
186.24812
Specification
98%
Research Area
Royal jelly acid (10-hydroxy-2-decenoic acid) is utilized in the pharmaceutical field primarily as a natural component with demonstrated antibacterial, anti-inflammatory, immunomodulatory, and tissue regeneration-promoting activities. It is commonly employed in research and development for adjunctive therapies targeting skin injuries, ulcers, and immune-related disorders.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Description
Royal Jelly Acid ((E)-Queen Bee Acid) is a major fatty acid with oral bioavailability, exhibiting neuroregulatory activity. Packing: 1kg/bag; 25kg/drum or as request Availability: In stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store sealed, protected from light, at 2-8°C.
References
[1]. Weiser MJ, et al. Long-Term Administration of Queen Bee Acid (QBA) to Rodents Reduces Anxiety-Like Behavior, Promotes Neuronal Health and Improves Body Composition. Nutrients. 2017 Dec 23;10(1).
[2]. Sugiyama T, et al. Royal jelly acid, 10-hydroxy-trans-2-decenoic acid, as a modulator of the innate immune responses. Endocrine, Metabolic & Immune Disorders Drug Targets. 2012 Dec;12(4):368-76.
[3]. Sugiyama T, et al. Inhibitory mechanism of 10-hydroxy-trans-2-decenoic acid (royal jelly acid) against lipopolysaccharide- and interferon-β-induced nitric oxide production. Inflammation. 2013 Apr;36(2):372-8.
[4]. Alkhaibari AM, et al. Insecticidal, Antimalarial, and Antileishmanial Effects of Royal Jelly and Its Three Main Fatty Acids, trans-10-Hydroxy-2-decenoic Acid, 10-Hydroxydecanoic Acid, and Sebacic Acid. Evidence-based Complementary and Alternative Medicine. 2022 Jan 20;2022:7425322.
[5]. Shahla J, et al. Comparative immunomodulatory effects of jelly royal and 10-H2DA on experimental autoimmune encephalomyelitis. Gene Reports. 2021;24:101217.
[6]. Jenkhetkan W, et al. Antiproliferative and cytotoxic efficacy of 10-hydroxy-2-decenoic acid, compared to doxorubicin, on MCF-7 breast cancer cells. Trends in Sciences. 2021;18(21):409.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
